Literature DB >> 33829305

Effects of remote ischemic conditioning on microcirculatory alterations in patients with sepsis: a single-arm clinical trial.

Inga Kiudulaite1, Egle Belousoviene1, Astra Vitkauskiene2, Andrius Pranskunas3.   

Abstract

BACKGROUND: Remote ischemic conditioning (RIC) is a promising technique that may protect organs and tissues from the effects of additional ischemic episodes. However, the therapeutic efficacy of RIC in humans with sepsis remains unknown. We hypothesized that RIC might improve sublingual microcirculation in patients with sepsis.
METHODS: This prospective single-arm trial was performed in a mixed ICU at a tertiary teaching hospital. We included patients with sepsis or septic shock within 24 h of ICU admission. The RIC procedure comprised 3 cycles of brachial cuff inflation to 200 mmHg for 5 min followed by deflation to 0 mmHg for another 5 min. The procedure took 30 min. RIC was performed at the time of study inclusion and repeated after 12 and 24 h. Sublingual microcirculatory measurements were obtained before and after each RIC procedure using a Cytocam®-incident dark-field (IDF) device (Braedius Medical, Huizen, The Netherlands). The microcirculatory data were compared with a historical control. Data are reported as the medians along with the 25th and 75th percentiles.
RESULTS: Twenty-six septic patients with a median age of 65 (57-81) years were enrolled in this study. The median Acute Physiology and Chronic Health Evaluation (APACHE) II and Sequential Organ Failure Assessment (SOFA) scores at admission were 20 (13-23) and 10 (9-12), respectively. All patients were receiving vasopressors. After the 1st RIC procedure, the microvascular flow index (MFI) and the proportion of perfused vessels (PPV) among small vessels were significantly higher than before the procedure, with pre- and post-treatment values of 2.17 (1.81-2.69) and 2.59 (2.21-2.83), respectively, for MFI (p = 0.003) and 87.9 (82.4-93.8) and 92.5 (87.9-96.1) %, respectively, for PPV (p = 0.026). This result was confirmed by comparison with a historical control group. We found no change in microcirculatory flow or density parameters during repeated RIC after 12 h and 24 h.
CONCLUSION: In patients with sepsis, the first remote ischemic conditioning procedure improved microcirculatory flow, whereas later procedures did not affect sublingual microcirculation. Trial registration NCT04644926, http://www.clinicaltrials.gov . Date of registration: 25 November 2020. Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT04644926 .

Entities:  

Keywords:  IDF imaging; Microcirculation; Remote ischemic conditioning

Year:  2021        PMID: 33829305     DOI: 10.1186/s13613-021-00848-y

Source DB:  PubMed          Journal:  Ann Intensive Care        ISSN: 2110-5820            Impact factor:   6.925


  33 in total

1.  RECAST (Remote Ischemic Conditioning After Stroke Trial): A Pilot Randomized Placebo Controlled Phase II Trial in Acute Ischemic Stroke.

Authors:  Timothy J England; Amanda Hedstrom; Saoirse O'Sullivan; Richard Donnelly; David A Barrett; Sarir Sarmad; Nikola Sprigg; Philip M Bath
Journal:  Stroke       Date:  2017-03-06       Impact factor: 7.914

2.  Acute and chronic remote ischemic conditioning attenuate septic cardiomyopathy, improve cardiac output, protect systemic organs, and improve mortality in a lipopolysaccharide-induced sepsis model.

Authors:  Takashi Honda; Quan He; Fangfei Wang; Andrew N Redington
Journal:  Basic Res Cardiol       Date:  2019-03-05       Impact factor: 17.165

3.  Randomized controlled trial of remote ischaemic conditioning in ST-elevation myocardial infarction as adjuvant to primary angioplasty (RIC-STEMI).

Authors:  António Gaspar; André P Lourenço; Miguel Álvares Pereira; Pedro Azevedo; Roberto Roncon-Albuquerque; Jorge Marques; Adelino F Leite-Moreira
Journal:  Basic Res Cardiol       Date:  2018-03-07       Impact factor: 17.165

4.  Frequency analysis of immunoglobulin V-gene expression and functional reactivities in bone marrow B cells.

Authors:  R Benner; A M Rijnbeek; M H Schreier; A Coutinho
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

5.  Survival benefits of remote ischemic conditioning in sepsis.

Authors:  Bellal Joseph; Mazhar Khalil; Ammar Hashmi; Louise Hecker; Narong Kulvatunyou; Andrew Tang; Randall S Friese; Peter Rhee
Journal:  J Surg Res       Date:  2016-02-18       Impact factor: 2.192

Review 6.  Remote ischaemic preconditioning: underlying mechanisms and clinical application.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  Cardiovasc Res       Date:  2008-05-02       Impact factor: 10.787

7.  Microcirculatory alterations in patients with severe sepsis: impact of time of assessment and relationship with outcome.

Authors:  Daniel De Backer; Katia Donadello; Yasser Sakr; Gustavo Ospina-Tascon; Diamantino Salgado; Sabino Scolletta; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2013-03       Impact factor: 7.598

Review 8.  Remote Ischemic Conditioning in Emergency Medicine-Clinical Frontiers and Research Opportunities.

Authors:  Andrew Fu Wah Ho; Jun Chong; Marcus Eng Hock Ong; Derek J Hausenloy
Journal:  Shock       Date:  2020-03       Impact factor: 3.454

9.  Remote ischemic conditioning: a promising therapeutic intervention for multi-organ protection.

Authors:  Da Zhou; Jiayue Ding; Jingyuan Ya; Liqun Pan; Yuan Wang; Xunming Ji; Ran Meng
Journal:  Aging (Albany NY)       Date:  2018-08-16       Impact factor: 5.682

Review 10.  Circulating mediators of remote ischemic preconditioning: search for the missing link between non-lethal ischemia and cardioprotection.

Authors:  Muntasir Billah; Anisyah Ridiandries; Usaid Allahwala; Harshini Mudaliar; Anthony Dona; Stephen Hunyor; Levon M Khachigian; Ravinay Bhindi
Journal:  Oncotarget       Date:  2019-01-04
View more
  2 in total

1.  Remote ischemic conditioning in septic shock: the RECO-Sepsis randomized clinical trial.

Authors:  Martin Cour; Kada Klouche; Bertrand Souweine; Jean-Pierre Quenot; Carole Schwebel; Sophie Perinel; Camille Amaz; Marielle Buisson; Michel Ovize; Nathan Mewton; Laurent Argaud
Journal:  Intensive Care Med       Date:  2022-09-14       Impact factor: 41.787

2.  RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.

Authors:  Sean M Davidson; Kishal Lukhna; Diana A Gorog; Alan D Salama; Alejandro Rosell Castillo; Sara Giesz; Pelin Golforoush; Siavash Beikoghli Kalkhoran; Sandrine Lecour; Aqeela Imamdin; Helison R P do Carmo; Ticiane Gonçalez Bovi; Mauricio W Perroud; Mpiko Ntsekhe; Andrei C Sposito; Derek M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  2021-06-25       Impact factor: 3.947

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.